Kang CK, Im YJ, Kim DY, Choe PG, et al. Immunogenicity and safety evaluation of a recombinant protective antigen anthrax vaccine (GC1109): A phase II, dose-confirmed, randomized, double-blind, placebo-controlled study. Vaccine 2025;65:127819.
PMID: 41067086